In contrast, for the W2C8 TCR with an Ackon of 2.1 × 10−6 μm4s−1 and a koff of 3.6/s, to achieve a similar amount of cumulative

lifetime, it would require a pMHC surface density of more than 50 000/μm2 despite a slower off-rate (and a longer lifetime). Therefore, the apparently faster 2D off-rates of more potent interactions can be effectively compensated by greatly boosted 2D on-rates in terms of total confinement LEE011 datasheet time as a result of fast serial TCR–pMHC engagement. It is well known that CD8/CD4 co-receptors greatly enhance T-cell responses to antigen stimulation [11, 34, 47]. However, the underlying mechanism is unclear. It has been proposed that CD8 binds to the same pMHC engaged with TCR to stabilize the TCR–pMHC interaction [47] and that co-receptors

(especially CD4) contribute to T-cell function by catalyzing the recruitment of Lck [47, 48]. SPR work using purified molecules reported discrepant results; some showed that CD8 enhances the TCR–pMHC interaction by reducing the off-rate [49] whereas others showed that TCR binds to pMHC independent of CD8 [50]. However, the work presented here and previous work by others [8, 51] demonstrate that CD8 significantly enhances pMHC tetramer staining of T cells. Tetramer technology is limited by low temporal resolution, low sensitivity, and difficulty to relate to intrinsic kinetic parameters [25]. Using the micropipette adhesion frequency method PFT�� with much higher sensitivity and temporal resolution, we have recently shown that in the OT1 and F5 TCR transgenic mouse systems, surrogate APCs adhere to naïve T cells in a two-stage fashion [34]. The first stage (<1 s contact time) is dominated by the TCR–pMHC interaction and the second stage (>1 s contact time) includes a significant CD8-dependent adhesion increase. The second-stage adhesion increment results from cooperative TCR–pMHC–CD8 trimeric interaction that requires cell signaling via Src kinases. In this study, we have shown that this is a shared feature Masitinib (AB1010) of the CD8+ hybridoma cells transfected with human TCRs.

However, in the gp209 system, the synergy indices Δ(/mpMHC) are much higher than what we previously observed, e.g. 0.2 μm2 (Fig. 6) and 0.023 μm2 [34] for the strongest interactions in this (19LF6) and the previous (OVA) studies, respectively. Interestingly, the much higher synergy indices correlate with the ∼ tenfold higher levels of CD8 than the gp209-specific TCRs expressed on the hybridoma cells (Fig. 1B). By comparison, the naïve T cells used in the previous study express ∼ twofold higher CD8 than OT1 TCR [34]. This suggests that the higher the CD8:TCR ratio, the greater the synergy. This study represents the first 2D kinetic analysis of recognition of a self-antigen by a panel of TCRs, which also differs from previous 2D kinetics studies using a single TCR to interact with a panel of variant pMHC ligands.